Literature DB >> 19948455

Management of vascular endothelial growth factor and multikinase inhibitor side effects.

Laura S Wood1.   

Abstract

The availability of vascular endothelial growth factor and multikinase inhibitors (MKIs) has enhanced treatment strategies for patients with advanced kidney cancer. Side effects associated with the agents include dermatologic toxicities, gastrointestinal toxicities, and hematologic and metabolic abnormalities that may interfere with treatment adherence. Nurses play a key role in managing side effects associated with emerging therapies. This article presents a case study to illustrate side-effect management strategies for patients receiving MKIs for the treatment of advanced renal cell carcinoma.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19948455     DOI： 10.1188/09.CJON.S2.13-18

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN： 1092-1095            Impact factor:   1.027


  8 in total

1.  Symptoms from treatment with sunitinib or sorafenib: a multicenter explorative cohort study to explore the influence of patient-reported outcomes on therapy decisions.

Authors:  J J Koldenhof; P O Witteveen; R de Vos; M Walraven; C N Tillier; H M W Verheul; S C C M Teunissen
Journal:  Support Care Cancer       Date:  2014-04-02       Impact factor: 3.603

Review 2.  Clinical presentation and management of hand-foot skin reaction associated with sorafenib in combination with cytotoxic chemotherapy: experience in breast cancer.

Authors:  Patricia Gomez; Mario E Lacouture
Journal:  Oncologist       Date:  2011-10-20

3.  Exfoliative esophagitis in a patient with metastatic renal cell carcinoma during sunitinib treatment.

Authors:  Jiwei Huang; Tianrong Wang; Yiran Huang
Journal:  Med Oncol       Date:  2013-01-03       Impact factor: 3.064

4.  Biological evaluation of a novel sorafenib analogue, t-CUPM.

Authors:  Aaron T Wecksler; Sung Hee Hwang; Jun-Yan Liu; Hiromi I Wettersten; Christophe Morisseau; Jian Wu; Robert H Weiss; Bruce D Hammock
Journal:  Cancer Chemother Pharmacol       Date:  2014-11-21       Impact factor: 3.333

5.  Antiangiogenic Effect of Ethanol Extract of Vigna angularis via Inhibition of Phosphorylation of VEGFR2, Erk, and Akt.

Authors:  Oh Sung Kwon; Myoung Seok Jeong; Bonglee Kim; Sung-Hoon Kim
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-19       Impact factor: 2.629

6.  A Rare Case of Sunitinib-Induced Exfoliative Esophagitis.

Authors:  Swapna Gayam; Ashwini Anumandla
Journal:  ACG Case Rep J       Date:  2016-11-23

7.  Novel method to identify group-specific non-catalytic pockets of human kinome for drug design.

Authors:  Huiwen Wang; Zeyu Guan; Jiadi Qiu; Ya Jia; Chen Zeng; Yunjie Zhao
Journal:  RSC Adv       Date:  2020-01-10       Impact factor: 3.361

8.  HKPocket: human kinase pocket database for drug design.

Authors:  Huiwen Wang; Jiadi Qiu; Haoquan Liu; Ying Xu; Ya Jia; Yunjie Zhao
Journal:  BMC Bioinformatics       Date:  2019-11-29       Impact factor: 3.169
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.